<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8D49A403-7D6B-4C9E-9188-13616E6DDCCF"><gtr:id>8D49A403-7D6B-4C9E-9188-13616E6DDCCF</gtr:id><gtr:name>University of Oklahoma</gtr:name><gtr:address><gtr:line1>550 Parrington Oval</gtr:line1><gtr:line4>Norman</gtr:line4><gtr:line5>OK 73019-3032</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8D49A403-7D6B-4C9E-9188-13616E6DDCCF"><gtr:id>8D49A403-7D6B-4C9E-9188-13616E6DDCCF</gtr:id><gtr:name>University of Oklahoma</gtr:name><gtr:address><gtr:line1>550 Parrington Oval</gtr:line1><gtr:line4>Norman</gtr:line4><gtr:line5>OK 73019-3032</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B6339638-7179-424B-A08E-AF3937B9474E"><gtr:id>B6339638-7179-424B-A08E-AF3937B9474E</gtr:id><gtr:firstName>Christoph</gtr:firstName><gtr:surname>Loenarz</gtr:surname><gtr:orcidId>0000-0002-8843-2531</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/938311FB-2998-4FA4-B30A-447B6572B1C0"><gtr:id>938311FB-2998-4FA4-B30A-447B6572B1C0</gtr:id><gtr:firstName>Christopher Joseph</gtr:firstName><gtr:surname>Schofield</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A902DB7E-5D05-49BC-BCD5-901CA428016D"><gtr:id>A902DB7E-5D05-49BC-BCD5-901CA428016D</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Ratcliffe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FJ003018%2F1"><gtr:id>8B60DC04-CDC5-49F2-9403-388F99C1FD43</gtr:id><gtr:title>Evolution of Oxygen Sensing in Animals</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J003018/1</gtr:grantReference><gtr:abstractText>The work we are proposing to do is based on insights we have obtained into the way humans sense oxygen. Regulating the delivery of oxygen to tissues is a problem for all organisms that use it as an energy source and particularly so for large animals such as humans that are composed of many billions of cells and different types of tissues. Many human diseases such as heart attacks, strokes, cancer, and anaemia involve damage to cell and hence tissue function by low oxygen levels (hypoxia). In previous work (important components of which were supported by the BBSRC) we have identified a group of oxygenases (enzymes that catalyse the incorporation of atmospheric oxygen into their substrates) that act as cellular 'oxygen sensors',by catalysing the hydroxylation (involving addition of an oxygen atom) of specific amino acid residues in a protein called HIF (hypoxia inducible factor). Hydroxylation destroys and inactivates HIF, but since it requires oxygen, this reaction is suppressed in hypoxia, allowing HIF to become activate in hypoxic cells (hence its name). HIF is a transcription factor (a regulator of gene expression) that, when switched on, regulates many genes that are involved in altering cell metabolism, growing new blood vessels, increasing blood production and other actions that help the body to survive hypoxia. These findings have opened up a new field of research on this type of protein modification, what it does, how it is regulated by hypoxia, and how it affects the cell's responses to hypoxia. The work on HIF has also raised many questions as to whether this type of modification (hydroxylation) occurs for other types of protein within cells, and what the effects might be. Recently, we have found that the HIF system also exists in the simplest living animal, Trichoplax adhaerens, which lives in the sea. Our initial data suggest that the Trichoplax oxygen sensing system is closely related to the human system, but is much simpler, largely because Trichoplax has a much smaller genome than humans. We aim to carry out a detailed comparison between the human and Trichoplax HIF systems, to investigate whether the HIF or related oxygen sensing systems exist in other organisms. Our initial data suggests that HIF is present in all animals but not in the group of organisms from which animals are though to have evolved (choanoflagellates), leading us to propose that the HIF system evolved along with the rises in oxygen levels and multicellular animals, at or just before the famous Precambrian period in the evolution of life. This aspect of evolution has been elegantly described in the recent television series 'First Life' presented by David Attenborough. However, we have also found that enzymes related to the HIF hydroxylases also exist in bacteria even though HIF doesn't. We think that these enzymes had an oxygen sensing role via an unknown mechanism in prokaryotes, and eventually evolved into the human oxygen sensing enzymes. Our work thus ultimately aims to connect molecular and genomic analyses with evolutionary studies. However, it is our experience that the cross-species analyses can lead to deeper understanding of the underlying mechanisms of how human cells work - these are often difficult to dissect because of the complexity of human cell biology. Finally, although our work will employ the use of invertebrates, aspects of their cell biology and embryonic development appear to be well conserved with human cells, raising the possibility that they may contribute to the replacement of mammals in drug development.</gtr:abstractText><gtr:technicalSummary>Following the definition of hydroxylation as regulating the transcriptional response of humans to hypoxia via the hypoxia inducible factor (HIF) system, we have focused work on the evolution of the HIF system and the possibility that post-translational hydroxylation has a wider role than previously considered. In initial work we have found that HIF itself, a HIF prolyl-hydroxylase (PHD), and the von Hippel Lindau protein which targets HIF for degradation, are functional in Trichoplax adhaerens, the simplest animal; Bioinformatic analyses suggest the HIF system occurs in all animals. We aim to investigate the extent of conservation of biochemical properties / roles of the HIF system components by a comparison of the 'key sensing' hydroxylases and their roles in T. adhaerens and other animals. The work will include detailed analyses including high-resolution structural analyses on the taPHD/HIF complexes Our second overall objective concerns the evolutionary origins of the HIF system in non-animals and the possibility that translation is regulated by 'oxygen sensing' enzymes related to the HIF hydroxylases. We have found that HIF is only present in animals. However, we have identified PHD-related enzymes in choanoflagellate animal precursors, in yeast and in prokaryotes. Cellular data suggests a role for these enzymes in hypoxic regulation in the role of gene expression. For homologues from Pseudomonas spp. we have identified a ribosomal elongation factor as a substrate opening up a new field in oxygen dependent signaling (and in prokaryotic post-translational modifications). We will thus work to define the roles of (candidate) PHD-homologous prolyl-hydroxylases from prokaryotes, yeasts, and animals in the regulation of gene expression at the level of translation. A key element of the proposed work will be investigations of the effects of hydroxylation on translational accuracy / efficiency.</gtr:technicalSummary><gtr:potentialImpactText>Impact Summary Who will benefit from the research? We intend that in the long term our research will benefit society in general by providing new insights into fundamental processes. Our results will be reported in the scientific literature. In the medium term (or shorter) we envisage that the work will be of interest to the pharmaceutical and biotechnological industries. Although not a focus of our current work we also believe that 2OG oxygenases have considerable potential as biocatalysts, as exemplified by the translation (by Kyowa-Hakko) of our work on proline-hydroxylases into a production procedure. The planned structural and biochemical analyses (in particular the high resolution crystallographic analyses) should be enabling with respect to protein engineering work on Oxygenases. Presently we believe that we are extremely fortunate to work in a field that is of both basic academic and commercial/translational interest (though this has not always been the case). If we succeed in our objectives, and our extensive preliminary data accumulated over &amp;gt;5 years of largely unpublished work suggests that we have a good chance of meeting most of them, the work should represent major advances in our understanding of hypoxic sensing. Although our objectives are aimed at addressing basic science questions, we believe the work is of substantial interest to the pharmaceutical industry both in terms of identifying new targets - Proteins involved in translation are of interest both as antibiotic targets and as human targets for cancer and inflammatory disease - and in terms of making more selective HIF hydroxylase inhibitors. The inhibition of non-hydroxylated over hydroxylated ribosomes is also of potential utility in targeting hypoxic tissues such as in tumours. The proposed work on the development of invertebrate animal models is also of interest from the perspective of 'ethical' drug development. Finally, the discovery of a direct role for 2OG oxygenase activity in translation will likely stimulate widespread interest in academia and industry, as occurred following the identification of the HIF hydroxylases and the JmjC histone modifying enzymes. How will they benefit? The work will provide new insights into how cells respond to limiting oxygen, a topic of basic interest to the many researchers working in signaling processes at biochemical, cellular and physiological levels. The objectives of the proposal are of interest to the pharmaceutical and biotechnological companies working on 2-oxoglutarate oxygenase inhibitors (including GSK, Merck, Amgen, Fibrogen, Astellas, Novartis, Johnson &amp;amp; Johnson, ReOx and others), for reasons including the following: i) The work will provide new insights into the fundamental mechanism of the role of 2OG oxygenases in hypoxia sensing in animals. ii) The work will provide high-resolution crystal structures for use in pharmaceutical design. iii) There is a reasonable likelihood that the work will lead to new pharmaceutical targets. iv) The work will help to enable the production of more selective oxygenase inhibitors. v) The work will develop and exemplify new methods for the functional assignment of genes/proteins at biochemical, cellular and physiological levels. vi) The work will help to enable protein engineering of 2OG oxygenases aimed at their cure in more efficient routes to pharmaceuticals. vii) The work will lead to the generation of new intellectual property of commercial value. viii) The work will help to retain and attract high quality researchers in / to the United Kingdom. ix) Because efficient oxygen supply is vital for all aspects of aerobic behaviour the proposed work is of interest to many sports especially high performance endurance sports, such as long distance cycling/running or sport at altitude (At the recent HypoxiaNet Conference at Davos (Jan 2011), an entire session was concerned with 'Exercise at High Altitude'.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>621578</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oklahoma</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Health Sciences Centre</gtr:department><gtr:description>Chris West collaboration</gtr:description><gtr:id>568EECDA-1E34-4A92-AA45-E2324EBE2574</gtr:id><gtr:impact>Final outcome of grant application awaited.</gtr:impact><gtr:partnerContribution>Provision of reagents for kinetic investigations.
NIH grant application that will benefit work in our group.
Academic discussion and design of future experiments.</gtr:partnerContribution><gtr:piContribution>Kinetic investigation of Toxoplasma gondii HIF hydroxylase homologue (PhyA) activity with respect to oxygen. 
Supply of a range of HIF hydroxylase inhibitors for screening as PhyA inhibitors.
Contribution to an NIH grant application to investigate prolyl hydroxylation and oxygen sensing in Toxoplasma gondii.
Academic discussion and design of future experiments.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar at the Department of Chemistry, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8E9DE413-D841-4014-8313-B70F4B58F20F</gtr:id><gtr:impact>Presentation at Seminar at the Department of Chemistry, Cambridge on &amp;quot;Chemistry of Oxygen Sensing in Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RSC Jeremy Knowles Lecture, St Andrews University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>72D5FF60-363C-4E70-9002-B362DFD136F9</gtr:id><gtr:impact>Talk at RSC Jeremy Knowles Lecture, St Andrews University, on &amp;quot;The chemistry of oxygen sensing in humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at '125 years of Chemistry at QML', Queen Mary's London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>57E8CF24-0A36-410E-AC5B-C098E0BB23E8</gtr:id><gtr:impact>Talk at '125 years of Chemistry at QML', Queen Mary's London on &amp;quot;The Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at UCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E1CCE139-2F85-4925-962E-EBEB35D991ED</gtr:id><gtr:impact>Seminar at University College London on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Cancer Research Horizons Meeting, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6A3CAA73-F12B-4FCA-ADB1-FB128A9E791A</gtr:id><gtr:impact>Talk at Oxford Cancer Research Horizons Meeting, Oxford on &amp;quot;Chemistry of Oxygen Sensing in Humans and other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at University of York</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E35DA829-39C6-4532-B282-B9235390E59C</gtr:id><gtr:impact>Seminar at University of York, on &amp;quot;Chemistry of Oxygen Sensing&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Konstanz University, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>087A44A1-8F20-4FE1-B633-A0B5927BC727</gtr:id><gtr:impact>Seminar at Konstanz University, Germany on &amp;quot;The Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Evotec</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA39D333-F8B5-44EC-8410-A3AA2FA32B01</gtr:id><gtr:impact>Talk at Evotec on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Huddersfield University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>018BFCA5-8E17-4D10-82CC-754736ED5FD8</gtr:id><gtr:impact>Seminar at Huddersfield University on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Introduction to Epigenetic Drug Discovery SCI workshop, Great Chesterford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4BB798EA-0419-45EA-831F-6A3A22EE4E8E</gtr:id><gtr:impact>Presentation at Introduction to Epigenetic Drug Discovery SCI workshop, Great Chesterford on &amp;quot;Is oxygen an epigenetic regulator?&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Frontiers in Biological Catalysis, Biochemical Society Symposium, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF84B30E-CABE-4AED-814C-E6C3E5AB646E</gtr:id><gtr:impact>Presenttion at Frontiers in Biological Catalysis, Biochemical Society Symposium, Cambridge on &amp;quot;The enzymology of oxygen sensing in animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society of Chemical Industry's London Region Committee, New York University London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32B29ECF-0E2E-4C0F-8487-FC8C21D81578</gtr:id><gtr:impact>Talk at Society of Chemical Industry's London Region Committee, New York University London on &amp;quot;The chemistry of oxygen sensing in humans and bacteria (from antibiotics to epigenetics and back again)&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Lillys</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2D2BCB5-2372-4FA0-9F63-00C9F8C55016</gtr:id><gtr:impact>Presentation at Seminar at Lillys, Erl Wood, Windlesham on &amp;quot;Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ELRIG Drug Discovery Workshop, University of Manchester</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A416F495-6C29-4540-9DCF-BA64912768D0</gtr:id><gtr:impact>Presentation at ELRIG Drug Discovery Workshop, University of Manchester on &amp;quot;Inhibiting Epigenetic Oxygenases&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lilly Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45F9BE72-E694-4409-A423-9F3757AD4FC6</gtr:id><gtr:impact>Presentation at Lilly's Chemical Biology meets Drug Discover conference on &amp;quot;Chemical Biology of Oxygen Sensing&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SEB 2014, Manchester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>75219E54-5F54-4F27-B5A2-FBE47722D7E6</gtr:id><gtr:impact>Presentation at The Society for Experimental Biology on &amp;quot;Hypoxia Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Japanese Embassy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>284659F0-2EEE-4119-A04B-867F5F37D82D</gtr:id><gtr:impact>Talk at Japanese Embassy on &amp;quot;The Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>COST Training School, Poitiers, France</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>131BDE58-40F0-4E5A-A57A-9580EBFBB3A7</gtr:id><gtr:impact>Presentation at 'Players of the Epigenetic Symphony' COST Training School, Poitiers, France on &amp;quot;The role of oxygenases in epigenetic regulation&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRC Enzyme, coenzymes and Metabolic Pathways, Waterville, USA</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9E9191C-0D49-4101-AF31-26964C2C3F7E</gtr:id><gtr:impact>Presentation Gordon Research Conference, Waterville, USA on &amp;quot;The Enzymology of Oxygen Sensing in Humans and Other Organisms&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Epigenetics' Select Biosciences Symposium, Boston, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FBD0AC4D-4572-477B-A472-ABAAD9177451</gtr:id><gtr:impact>Talk at 'Epigenetics' Select Biosciences Symposium, Boston, USA on &amp;quot;The role of oxygenases in epigenetics&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Aberdeen University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99DCAAE0-56D2-49CF-97AF-066019B9521E</gtr:id><gtr:impact>Seminar at Aberdeen University on &amp;quot;The Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mill Hill Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A0D32A58-D41D-4155-8874-17D14BD512C3</gtr:id><gtr:impact>Mill Hill Lecture, MRC National Institute for Medical Research, London on &amp;quot;Chemistry of Oxygen Sensing in Humans&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISMB Symposium, Birkbeck College, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF5FBE45-0463-43CA-AFC4-65F4AA27F662</gtr:id><gtr:impact>Presentation at Institute of Structural Molecular Biology (ISMB) Symposium on &amp;quot;Regulation of gene expression by oxygen&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at CICB Paris</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4DCF8B3-0463-41A0-9954-A4B05377E059</gtr:id><gtr:impact>Talk at Seminar at Interdisciplinary Center Chemistry Biology-Paris (CICB-Paris) on &amp;quot;The Chemistry of Oxford Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>66F2D462-880C-46EB-8CDB-E38A76368820</gtr:id><gtr:impact>Seminar at Bristol University on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CIPSM Oktoberfest, Munich, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>280D27AF-F27A-404C-BF3C-0E61C03D58C2</gtr:id><gtr:impact>Talk at CIPSM Oktoberfest, Munich, Germany on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at University of Dundee</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8315A040-FF62-4BCA-887D-82D1BCBCBE42</gtr:id><gtr:impact>Presentation at Seminar at University of Dundee on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Bayer, Berlin, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B2CFB8D7-9E1F-4848-8867-E8AD250C80A0</gtr:id><gtr:impact>Talk at Bayer, Berlin, Germany on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Redox Modulation of Health and Disease: From Inorganic Chemistry to Translational Medicine' Meeting, Erlangen, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D71CA6D5-B466-4DAB-999A-445259E554CE</gtr:id><gtr:impact>Talk at 'Redox Modulation of Health and Disease: From Inorganic Chemistryto Translational Medicine' Meeting, Erlangen, Germany on &amp;quot;The Chemistry of Oxygen Sensing in Humans and Other Animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>OCISB 2012 Conference, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>324ED1AD-345E-441E-8825-979A664EFF9C</gtr:id><gtr:impact>Presentation at OCISB 2012 Conference, Oxford Systems Biology: Building Networks and Bridging Scales, Oxford on &amp;quot;Towards a chemical understanding of hypoxic sensing in animals&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chemical Biology and Molecular Medicine (CBMM)  Annual Symposium, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6106C2CC-0DAB-4570-80D2-07CB03CE339D</gtr:id><gtr:impact>Talk at CBMM Annual Symposium, Cambridge on 'Chemistry of Oxygen Sensing'</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The work will help to enable drug discovery efforts centred on the human 2-oxoglutarate dependent oxygenases. The identification of OGFOD1 as a functionally conserved oxygenase, the active site of which is closely related to the human hypoxia inducible factory prolyl hydroxylases (PHDs) has implications for the development of selective PHD inhibitors for the treatment of anaemia and other ischaemia related disorders. We have shown that at least some PHD inhibitors in clinical trials inhibit OGFOD1. The identification of OGFOD1 as a ribosomal oxygenase also raises the possibility that modulation of its activity may be used to treat genetic diseases associated with stop codon readthrough.</gtr:description><gtr:id>AA5B988D-C143-41C7-A313-EDF8F8B93BA0</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The invention is an assay that identifies modulators of OGFOD1 activity. The assay can be used to find potential drugs against a number of genetic diseases (such as cystic fibrosis, haemophilia or muscular dystrophy) or viral conditions such as HIB.</gtr:description><gtr:id>63A61C87-BD49-460C-84AC-38E96A865D1D</gtr:id><gtr:impact>OGFOD is of interest as a target and is also of use in selectivity screens for other human 2-oxoglutarate oxygenases.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>EP2675912</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>OGFOD1 - European patent</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The invention is an assay that identifies modulators of OGFOD1 activity. The assay can be used to find potential drugs against a number of genetic diseases (such as cystic fibrosis, haemophilia or muscular dystrophy) or viral conditions such as HIV.</gtr:description><gtr:id>D60CCD43-CBCF-4D73-BB95-D8FEA153A202</gtr:id><gtr:impact>OGFOD is of interest as a target and is also of use in selectivity screens for other human 2-oxoglutarate oxygenases.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>US9228224</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>METHOD FOR ASSAYING OGFOD1 ACTIVITY - US patent</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Our work aimed to provide detailed insights into the evolution of hypoxia sensing in animals.
All the key objectives of our proposed work have been met. We have carried out detailed structural (including high-resolution crystallography) and kinetic analyses on the hypoxia inducible factor prolyl hydroxylase from the simplest animal, Trichoplax adhaerens, and shown that it is remarkably similar in these regards to the most important human hypoxia sensing prolyl hydroxylase (PHDs). The results have not only defined the limits of the hypoxia sensing system present in humans as being to the animal kingdom, but have identified the first prolyl hydroxylase to be identified in a prokaryote. They have also identified and characterised (including by crystal structures) a new type of prolyl hydroxylase present in organisms ranging from yeasts to humans. In yeasts the hydroxylase catalyses an unprecedented di-hydroxylation of a prolyl residue present in a key component (RP23) of the ribosome. In addition to informing in the evolution of oxygen sensing the results will aid in the pharmaceutical development of selective oxygenase inhibitors.</gtr:description><gtr:exploitationPathways>Future work can include further studies on the regulation of translation by oxygenases and the use of the 'new' human studies (OGFOD1) in oxygenase work on the development of selective inhibition for the human hypoxia inducible factor prolyl hydroxlases.</gtr:exploitationPathways><gtr:id>1B556A29-E536-461C-AF64-AC5594B5884F</gtr:id><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/717A825A-DF51-40D4-9546-352DD831BDB6"><gtr:id>717A825A-DF51-40D4-9546-352DD831BDB6</gtr:id><gtr:title>The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a9ae3828c3a863983fefd000fae9625"><gtr:id>0a9ae3828c3a863983fefd000fae9625</gtr:id><gtr:otherNames>Loenarz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6033D5EA-12A8-439D-A038-7666A6A5517B"><gtr:id>6033D5EA-12A8-439D-A038-7666A6A5517B</gtr:id><gtr:title>Structure and Mechanism of a Viral Collagen Prolyl Hydroxylase.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14286858b70a53acb88cde07439d5f6c"><gtr:id>14286858b70a53acb88cde07439d5f6c</gtr:id><gtr:otherNames>Longbotham JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A5CF940-66C2-4962-AECF-50BC19D6B68A"><gtr:id>9A5CF940-66C2-4962-AECF-50BC19D6B68A</gtr:id><gtr:title>Ribosomal oxygenases are structurally conserved from prokaryotes to humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AEE84AA-7BB3-4B2E-A687-C5BDE35D1FFE"><gtr:id>7AEE84AA-7BB3-4B2E-A687-C5BDE35D1FFE</gtr:id><gtr:title>A photoreactive small-molecule probe for 2-oxoglutarate oxygenases.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/07b6a8772ca06e43e6870f121d19eb78"><gtr:id>07b6a8772ca06e43e6870f121d19eb78</gtr:id><gtr:otherNames>Rotili D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C08C3208-3204-4A62-81FA-0F064165746C"><gtr:id>C08C3208-3204-4A62-81FA-0F064165746C</gtr:id><gtr:title>Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/edd8047364797ec869c89f40f46ac93c"><gtr:id>edd8047364797ec869c89f40f46ac93c</gtr:id><gtr:otherNames>Katz MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F39D4976-C4BA-4861-81E5-443CE191861A"><gtr:id>F39D4976-C4BA-4861-81E5-443CE191861A</gtr:id><gtr:title>OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfe4d5a73e12e8b514864228f44c86fd"><gtr:id>bfe4d5a73e12e8b514864228f44c86fd</gtr:id><gtr:otherNames>Singleton RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74A83DBF-3808-4662-A468-1361301EFF71"><gtr:id>74A83DBF-3808-4662-A468-1361301EFF71</gtr:id><gtr:title>Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfcea710476afcf5160f03e6a5269b85"><gtr:id>bfcea710476afcf5160f03e6a5269b85</gtr:id><gtr:otherNames>Tarhonskaya H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D15A4E9-5A5A-4FFD-830C-3A203E44FE83"><gtr:id>5D15A4E9-5A5A-4FFD-830C-3A203E44FE83</gtr:id><gtr:title>Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a9ae3828c3a863983fefd000fae9625"><gtr:id>0a9ae3828c3a863983fefd000fae9625</gtr:id><gtr:otherNames>Loenarz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5DED8CA-2697-4C0F-B634-D6F89F4213F8"><gtr:id>B5DED8CA-2697-4C0F-B634-D6F89F4213F8</gtr:id><gtr:title>Targeting Protein-Protein Interactions in the HIF System.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5cc1397c7fb5fb5593e914b680ac490"><gtr:id>e5cc1397c7fb5fb5593e914b680ac490</gtr:id><gtr:otherNames>Wilkins SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC5E51DB-ABE5-4CD5-8DD5-1DB182345CCF"><gtr:id>DC5E51DB-ABE5-4CD5-8DD5-1DB182345CCF</gtr:id><gtr:title>Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5d90e340706ff84958065e3f43f2ff2"><gtr:id>e5d90e340706ff84958065e3f43f2ff2</gtr:id><gtr:otherNames>Markolovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB4753FC-366C-4450-A77B-18DC2255E530"><gtr:id>AB4753FC-366C-4450-A77B-18DC2255E530</gtr:id><gtr:title>Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfcea710476afcf5160f03e6a5269b85"><gtr:id>bfcea710476afcf5160f03e6a5269b85</gtr:id><gtr:otherNames>Tarhonskaya H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE152F9E-7B96-4EE2-9442-5840C8A976F7"><gtr:id>DE152F9E-7B96-4EE2-9442-5840C8A976F7</gtr:id><gtr:title>Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9045b55ae29d2b47ed2ed807e187fa3d"><gtr:id>9045b55ae29d2b47ed2ed807e187fa3d</gtr:id><gtr:otherNames>Tan SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EAD7EF0-E3BD-4266-8C06-E6B48C0C3E5F"><gtr:id>3EAD7EF0-E3BD-4266-8C06-E6B48C0C3E5F</gtr:id><gtr:title>Pharmacological targeting of the HIF hydroxylases--A new field in medicine development.</gtr:title><gtr:parentPublicationTitle>Molecular aspects of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0ca40f3ffbff7ce1bc16f3cc322e90d"><gtr:id>f0ca40f3ffbff7ce1bc16f3cc322e90d</gtr:id><gtr:otherNames>Chan MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-2997</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30ACDDFA-897B-48CD-AB88-BA1924145264"><gtr:id>30ACDDFA-897B-48CD-AB88-BA1924145264</gtr:id><gtr:title>Abstracts of the 22nd International Isotope Society (UK Group) Symposium: synthesis and applications of labelled compounds 2013</gtr:title><gtr:parentPublicationTitle>Journal of Labelled Compounds and Radiopharmaceuticals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e9e3a2e181a82c844a02503bfbb5901c"><gtr:id>e9e3a2e181a82c844a02503bfbb5901c</gtr:id><gtr:otherNames>Aboagye E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC86EA5D-BB0B-4613-9453-757BC89C4BCD"><gtr:id>EC86EA5D-BB0B-4613-9453-757BC89C4BCD</gtr:id><gtr:title>Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f38abb02b1e65a28453c45ca199b71f"><gtr:id>9f38abb02b1e65a28453c45ca199b71f</gtr:id><gtr:otherNames>Ge W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DBEC0F01-4727-4236-A1AE-51B7E562D043"><gtr:id>DBEC0F01-4727-4236-A1AE-51B7E562D043</gtr:id><gtr:title>Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c36713eaa4b41ed6dc5a444a4151007b"><gtr:id>c36713eaa4b41ed6dc5a444a4151007b</gtr:id><gtr:otherNames>Scotti JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87BC5257-2DA8-4FAB-A1D6-71B0E73F1516"><gtr:id>87BC5257-2DA8-4FAB-A1D6-71B0E73F1516</gtr:id><gtr:title>Is JmjC oxygenase catalysis limited to demethylation?</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e8fc7c1e97c29c30a042662842bb2c6c"><gtr:id>e8fc7c1e97c29c30a042662842bb2c6c</gtr:id><gtr:otherNames>Hopkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC17DD76-3762-4B22-A76E-16D26D381F5F"><gtr:id>EC17DD76-3762-4B22-A76E-16D26D381F5F</gtr:id><gtr:title>Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0ca40f3ffbff7ce1bc16f3cc322e90d"><gtr:id>f0ca40f3ffbff7ce1bc16f3cc322e90d</gtr:id><gtr:otherNames>Chan MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D6DE24E-5BE8-45E0-9B0C-D832F6F93720"><gtr:id>5D6DE24E-5BE8-45E0-9B0C-D832F6F93720</gtr:id><gtr:title>Analysis of JmjC Demethylase-Catalyzed Demethylation Using Geometrically-Constrained Lysine Analogues.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5807c17e3d25eb3b7879aa70126ddb96"><gtr:id>5807c17e3d25eb3b7879aa70126ddb96</gtr:id><gtr:otherNames>Langley GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/308F353C-D7AA-4ECC-952A-871A1B7A449C"><gtr:id>308F353C-D7AA-4ECC-952A-871A1B7A449C</gtr:id><gtr:title>Studies on deacetoxycephalosporin C synthase support a consensus mechanism for 2-oxoglutarate dependent oxygenases.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfcea710476afcf5160f03e6a5269b85"><gtr:id>bfcea710476afcf5160f03e6a5269b85</gtr:id><gtr:otherNames>Tarhonskaya H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6490A9FC-84FD-4577-A30E-163985257BB3"><gtr:id>6490A9FC-84FD-4577-A30E-163985257BB3</gtr:id><gtr:title>Pharmacological targeting of the HIF hydroxylases--A new field in medicine development.</gtr:title><gtr:parentPublicationTitle>Molecular aspects of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0ca40f3ffbff7ce1bc16f3cc322e90d"><gtr:id>f0ca40f3ffbff7ce1bc16f3cc322e90d</gtr:id><gtr:otherNames>Chan MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-2997</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J003018/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>